{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:55:02Z","timestamp":1771905302956,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Plasma cell disorders are one of the most common hematologic malignancies. Monoclonal gammopathy of undetermined significance (MGUS) is defined by a serum monoclonal protein &lt;3\u2009g\/dL, bone marrow plasma cell infiltration &lt;10%, and most importantly absence of end-organ damage. The prevalence of MGUS in general population is estimated to be 1%\u20134% and its frequency increases with age with 3% among people above 50 y of age. The risk of progression to clinically significant plasma cell dyscrasia is estimated to be 1% per year. With aging population and increasing use of transplantation for the management of kidney disease in older adults, MGUS is being identified during the evaluation for kidney transplant candidacy or during the postkidney transplant follow-up. MGUS in patients with end-stage renal disease (ESRD) undergoing evaluation for kidney transplant can pose a complex management dilemma. In this article, we review the current state of knowledge about the prevalence of MGUS in ESRD population and the impact of kidney transplantation on the progression of MGUS to clinically significant plasma cell disorder. We make recommendations for the screening of ESRD patients undergoing kidney transplant evaluation and the management of MGUS after renal transplant.<\/jats:p>","DOI":"10.1097\/txd.0000000000001176","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T22:02:30Z","timestamp":1701468150000},"page":"e723","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance"],"prefix":"10.1097","volume":"7","author":[{"given":"Nabeel","family":"Aslam","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic Florida, Jacksonville, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Trautman","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic Florida, Jacksonville, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taimur","family":"Sher","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"R1-20240805","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1001\/jama.1992.03490200198025","article-title":"Plasma cell dyscrasias.","volume":"268","author":"Barlogie","year":"1992","journal-title":"JAMA"},{"key":"R2-20240805","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.2215\/CJN.02560316","article-title":"Paraprotein-related kidney disease: kidney injury from paraproteins-what determines the site of injury?","volume":"11","author":"Doshi","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-20240805","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma.","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"R4-20240805","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance.","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"R5-20240805","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"R8-20240805","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.2215\/CJN.06210518","article-title":"Association of monoclonal gammopathy with progression to ESKD among US veterans.","volume":"13","author":"Burwick","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-20240805","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1399-0012.2011.01539.x","article-title":"Initial survival data of kidney transplant patients with pre-transplant monoclonal gammopathy.","volume":"26","author":"Soltero","year":"2012","journal-title":"Clin Transplant"},{"key":"R10-20240805","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.transproceed.2014.11.021","article-title":"Follow-up monoclonal gammopathy of undetermined significance in kidney transplant.","volume":"47","author":"Cu\u00e9llar-Garc\u00eda","year":"2015","journal-title":"Transplant Proc"},{"key":"R11-20240805","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000337482","article-title":"Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.","volume":"35","author":"Naina","year":"2012","journal-title":"Am J Nephrol"},{"key":"R12-20240805","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1097\/TXD.0000000000000937","article-title":"The evolution of monoclonal gammopathy of undetermined significance in kidney transplant recipients.","volume":"5","author":"Gagnon","year":"2019","journal-title":"Transplant Direct"},{"key":"R13-20240805","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/lt.500020508","article-title":"Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder.","volume":"2","author":"Badley","year":"1996","journal-title":"Liver Transpl Surg"},{"key":"R14-20240805","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.transproceed.2004.09.046","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr Virus (EBV) latently infected B lymphocytes in long-term renal transplant patients.","volume":"36","author":"Babel","year":"2004","journal-title":"Transplant Proc"},{"key":"R15-20240805","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.transproceed.2015.08.023","article-title":"Outcomes of monoclonal gammopathy of undetermined significance in patients who underwent kidney transplantation.","volume":"47","author":"Bancu","year":"2015","journal-title":"Transplant Proc"},{"key":"R16-20240805","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1097\/TP.0000000000001884","article-title":"Monoclonal gammopathy of undetermined significance after kidney transplantation: single-center experience.","volume":"101","author":"Alfano","year":"2017","journal-title":"Transplantation"},{"key":"R17-20240805","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/TP.0b013e318225db2c","article-title":"Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.","volume":"92","author":"Jimenez-Zepeda","year":"2011","journal-title":"Transplantation"},{"key":"R18-20240805","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000168712","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients.","volume":"14","author":"Rostaing","year":"1994","journal-title":"Am J Nephrol"},{"key":"R19-20240805","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1093\/oxfordjournals.ndt.a027215","article-title":"Monoclonal gammopathy after intense induction immunosuppression in renal transplant patients.","volume":"11","author":"Passweg","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R20-20240805","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma.","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"R21-20240805","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41408-019-0263-z","article-title":"Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.","volume":"9","author":"Murray","year":"2019","journal-title":"Blood Cancer J"},{"key":"R22-20240805","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41408-021-00408-4","article-title":"Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an international myeloma working group mass spectrometry committee report.","volume":"11","author":"Murray","year":"2021","journal-title":"Blood Cancer J"},{"key":"R23-20240805","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.","volume":"15","author":"Leung","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"R24-20240805","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ki.2010.1","article-title":"Recurrent membranoproliferative glomerulonephritis after kidney transplantation.","volume":"77","author":"Lorenz","year":"2010","journal-title":"Kidney Int"},{"key":"R25-20240805","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.ajkd.2016.04.021","article-title":"Recurrent light chain proximal tubulopathy in a kidney allograft.","volume":"68","author":"Angioi","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R26-20240805","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/MNH.0000000000000544","article-title":"Current opinions in nephrology and hypertension: kidney transplantation in patients with plasma cell dyscrasias.","volume":"28","author":"Lum","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R27-20240805","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance.","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"key":"R28-20240805","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2","article-title":"International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.","volume":"20","author":"Hillengass","year":"2019","journal-title":"Lancet Oncol"},{"key":"R29-20240805","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/jamaoncol.2019.1568","article-title":"Association of immune marker changes with progression of monoclonal gammopathy of undetermined significance to multiple myeloma.","volume":"5","author":"Landgren","year":"2019","journal-title":"JAMA Oncol"},{"key":"R30-20240805","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3109\/0886022X.2015.1044402","article-title":"Outcomes of living kidney donors with monoclonal gammopathy of undetermined significance.","volume":"37","author":"Cheungpasitporn","year":"2015","journal-title":"Ren Fail"},{"key":"R31-20240805","first-page":"256","article-title":"Monoclonal gammopathy of undetermined significance: a contraindication for living kidney donation?","volume":"4","author":"Serra","year":"2011","journal-title":"NDT Plus"},{"key":"R32-20240805","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1111\/ajt.13804","article-title":"Donor monoclonal gammopathy may cause lymphoproliferative disorders in solid organ transplant recipients.","volume":"16","author":"Felldin","year":"2016","journal-title":"Am J Transplant"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:04:55Z","timestamp":1722834295000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001176","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]}}}